Two Sigma Investments, LP Protalix Bio Therapeutics, Inc. Transaction History
Two Sigma Investments, LP
- $50.6 Billion
- Q2 2025
A detailed history of Two Sigma Investments, LP transactions in Protalix Bio Therapeutics, Inc. stock. As of the latest transaction made, Two Sigma Investments, LP holds 71,537 shares of PLX stock, worth $117,320. This represents 0.0% of its overall portfolio holdings.
Number of Shares
71,537
Previous 86,354
17.16%
Holding current value
$117,320
Previous $221,000
52.49%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding PLX
# of Institutions
67Shares Held
8.7MCall Options Held
180KPut Options Held
10.6K-
Jim Simons Renaissance Technologies LLC | New York, Ny1.62MShares$2.65 Million0.0% of portfolio
-
Northern Trust Corp Chicago, IL1.08MShares$1.77 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA826KShares$1.36 Million0.0% of portfolio
-
Connor, Clark & Lunn Investment Management Ltd.496KShares$813,7940.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA485KShares$795,0680.0% of portfolio
About Protalix BioTherapeutics, Inc.
- Ticker PLX
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 49,753,400
- Market Cap $81.6M
- Description
- Protalix BioTherapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx plant cell-based protein expression system in the United States, Australia, Canada, Israel, Brazil, Russia, Turkey, and internationally. The company offers Elelyso fo...